Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease
- PMID: 15681497
- PMCID: PMC1747292
- DOI: 10.1136/thx.2004.023986
Enhanced bronchial expression of vascular endothelial growth factor and receptors (Flk-1 and Flt-1) in patients with chronic obstructive pulmonary disease
Abstract
Background: Ongoing inflammatory processes resulting in airway and vascular remodelling characterise chronic obstructive pulmonary disease (COPD). Vascular endothelial growth factor (VEGF) and its receptors VEGFR-1 (Flt-1) and VEGFR-2 (KDR/Flk-1) could play a role in tissue remodelling and angiogenesis in COPD.
Methods: The cellular expression pattern of VEGF, Flt-1, and KDR/Flk-1 was examined by immunohistochemistry in central and peripheral lung tissues obtained from ex-smokers with COPD (forced expiratory volume in 1 second (FEV(1)) <75% predicted; n = 14) or without COPD (FEV(1) >85% predicted; n = 14). The immunohistochemical staining of each molecule was quantified using a visual scoring method with grades ranging from 0 (no) to 3 (intense).
Results: VEGF, Flt-1, and KDR/Flk-1 immunostaining was localised in vascular and airway smooth muscle (VSM and ASM) cells, bronchial, bronchiolar and alveolar epithelium, and macrophages. Pulmonary endothelial cells expressed Flt-1 and KDR/Flk-1 abundantly but not VEGF. Bronchial VEGF expression was higher in microvascular VSM cells and ASM cells of patients with COPD than in patients without COPD (1.7 and 1.6-fold, p<0.01, respectively). VEGF expression in intimal and medial VSM (1.7 and 1.3-fold, p<0.05) of peripheral pulmonary arteries associated with the bronchiolar airways was more intense in COPD, as was VEGF expression in the small pulmonary vessels in the alveolar region (1.5 and 1.7-fold, p<0.02). In patients with COPD, KDR/Flk-1 expression was enhanced in endothelial cells and in intimal and medial VSM (1.3, 1.9 and 1.5-fold, p<0.02) while endothelial Flt-1 expression was 1.7 times higher (p<0.03). VEGF expression was significantly increased in bronchiolar and alveolar epithelium as well as in bronchiolar macrophages (1.5-fold, p<0.001). The expression of VEGF in bronchial VSM and mucosal microvessels as well as bronchiolar epithelium was inversely correlated with FEV(1) (r<-0.45; p<0.01).
Conclusions: VEGF and its receptors Flt-1 and KDR/Flk-1 may be involved in peripheral vascular and airway remodelling processes in an autocrine and/or paracrine manner. This system may also be associated with epithelial cell viability during airway wall remodelling in COPD.
Comment in
-
Angiogenesis and vascular endothelial growth factor in COPD.Thorax. 2005 Feb;60(2):88-9. doi: 10.1136/thx.2004.030544. Thorax. 2005. PMID: 15681489 Free PMC article. No abstract available.
Similar articles
-
Gene expression of vascular endothelial growth factor and its receptors and angiogenesis in bronchial asthma.J Allergy Clin Immunol. 2001 Jun;107(6):1034-8. doi: 10.1067/mai.2001.115626. J Allergy Clin Immunol. 2001. PMID: 11398081
-
Immunohistochemical localization of vascular endothelial growth factor (VEGF) and its two specific receptors, Flt-1 and KDR, in the porcine placenta and non-pregnant uterus.Placenta. 1999 Jan;20(1):35-43. doi: 10.1053/plac.1998.0350. Placenta. 1999. PMID: 9950143
-
[Expressions of and the effect of smoking on vascular endothelial growth factor and induced nitric oxide synthase in lung tissues of chronic obstructive pulmonary disease patients].Zhonghua Jie He He Hu Xi Za Zhi. 2007 Aug;30(8):573-6. Zhonghua Jie He He Hu Xi Za Zhi. 2007. PMID: 17988548 Chinese.
-
Role of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease.Med Sci Monit. 2007 Nov;13(11):RA189-195. Med Sci Monit. 2007. PMID: 17968307 Review.
-
Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview.Clin Exp Allergy. 2004 Aug;34(8):1156-67. doi: 10.1111/j.1365-2222.2004.02030.x. Clin Exp Allergy. 2004. PMID: 15298554 Review.
Cited by
-
Cigarette smoke reversibly activates hypoxia-inducible factor 1 in a reactive oxygen species-dependent manner.Sci Rep. 2016 Sep 29;6:34424. doi: 10.1038/srep34424. Sci Rep. 2016. PMID: 27680676 Free PMC article.
-
From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling.Front Pediatr. 2016 Aug 17;4:80. doi: 10.3389/fped.2016.00080. eCollection 2016. Front Pediatr. 2016. PMID: 27583245 Free PMC article. Review.
-
Clinical implications for vascular endothelial growth factor in the lung: friend or foe?Respir Res. 2006 Oct 17;7(1):128. doi: 10.1186/1465-9921-7-128. Respir Res. 2006. PMID: 17044926 Free PMC article. Review.
-
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.Cells. 2022 May 23;11(10):1720. doi: 10.3390/cells11101720. Cells. 2022. PMID: 35626756 Free PMC article. Review.
-
Epac1 and Epac2 are differentially involved in inflammatory and remodeling processes induced by cigarette smoke.FASEB J. 2014 Nov;28(11):4617-28. doi: 10.1096/fj.13-248930. Epub 2014 Aug 7. FASEB J. 2014. PMID: 25103224 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical